This announcement is a separate document:
李氏大藥廠:建議將Zhaoke Ophthalmology Limited分拆及於聯交所主板獨立上市的最新情況 - 記錄日期、暫停辦理股份過戶登記手續及合資格股東於優先發售享有保證配額的基準
LEE'S PHARM: Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Record Date, Closure of Register of Members and Basis of The Assured Entitlement of Qualifying Shareholders in The
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.